Product Code: ETC6188189 | Publication Date: Sep 2024 | Updated Date: May 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The treatment market for pharyngitis includes antibiotics, analgesics, and throat lozenges. There is growing emphasis on antimicrobial stewardship to reduce unnecessary antibiotic prescriptions and the development of resistance.
Treatment trends in the pharyngitis market are leaning toward evidence-based prescribing, with an emphasis on reducing unnecessary antibiotic use. Telehealth services have made diagnosis and treatment more accessible, particularly in rural areas. Additionally, there is a growing market for throat sprays, medicated lozenges, and supportive therapies, with consumer preference shifting toward over-the-counter and natural remedies for mild cases.
Challenges in this market stem from diagnostic limitations and over-the-counter (OTC) product misuse. Ensuring appropriate antibiotic stewardship while providing effective symptomatic relief products requires a balance that has been difficult to achieve, especially in rural healthcare settings.
Public health initiatives focused on minimizing antibiotic resistance create investment opportunities in alternative treatments and diagnostics for pharyngitis. Government support for clinical trials and non-antibiotic therapies, especially in pediatric care, enhances commercial prospects in this segment.
Treatment-related policies are focused on primary healthcare accessibility, with general practitioners (GPs) playing a central role in diagnosing and treating pharyngitis. Government-funded bulk billing under Medicare allows for free GP consultations, which supports early diagnosis and treatment. Furthermore, antimicrobial prescribing guidelines are regularly updated to align with national resistance surveillance data.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Pharyngitis Treatment Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Pharyngitis Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Pharyngitis Treatment Market - Industry Life Cycle |
3.4 Australia Pharyngitis Treatment Market - Porter's Five Forces |
3.5 Australia Pharyngitis Treatment Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Australia Pharyngitis Treatment Market Revenues & Volume Share, By Mode of Delivery, 2021 & 2031F |
3.7 Australia Pharyngitis Treatment Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.8 Australia Pharyngitis Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Pharyngitis Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Pharyngitis Treatment Market Trends |
6 Australia Pharyngitis Treatment Market, By Types |
6.1 Australia Pharyngitis Treatment Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Australia Pharyngitis Treatment Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Australia Pharyngitis Treatment Market Revenues & Volume, By Macrolides, 2021- 2031F |
6.1.4 Australia Pharyngitis Treatment Market Revenues & Volume, By Beta Lactam, 2021- 2031F |
6.1.5 Australia Pharyngitis Treatment Market Revenues & Volume, By Tetracycline, 2021- 2031F |
6.1.6 Australia Pharyngitis Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia Pharyngitis Treatment Market, By Mode of Delivery |
6.2.1 Overview and Analysis |
6.2.2 Australia Pharyngitis Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Australia Pharyngitis Treatment Market Revenues & Volume, By Intravenous Intramuscular, 2021- 2031F |
6.2.4 Australia Pharyngitis Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Pharyngitis Treatment Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 Australia Pharyngitis Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Australia Pharyngitis Treatment Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.4 Australia Pharyngitis Treatment Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.3.5 Australia Pharyngitis Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Australia Pharyngitis Treatment Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Australia Pharyngitis Treatment Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Australia Pharyngitis Treatment Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.4.4 Australia Pharyngitis Treatment Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Australia Pharyngitis Treatment Market Import-Export Trade Statistics |
7.1 Australia Pharyngitis Treatment Market Export to Major Countries |
7.2 Australia Pharyngitis Treatment Market Imports from Major Countries |
8 Australia Pharyngitis Treatment Market Key Performance Indicators |
9 Australia Pharyngitis Treatment Market - Opportunity Assessment |
9.1 Australia Pharyngitis Treatment Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Australia Pharyngitis Treatment Market Opportunity Assessment, By Mode of Delivery, 2021 & 2031F |
9.3 Australia Pharyngitis Treatment Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.4 Australia Pharyngitis Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Pharyngitis Treatment Market - Competitive Landscape |
10.1 Australia Pharyngitis Treatment Market Revenue Share, By Companies, 2024 |
10.2 Australia Pharyngitis Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |